• News Feeds
Page last updated at 08:01 GMT, Friday, 6 July 2012 09:01 UK

Head of ABPI: 'We are trying to address these trust issues'

Advertisement

Drug company GlaxoSmithKline pleaded guilty to violations involving 10 drugs and was ordered to pay a fine of $3bn.

Stephen Whitehead, chief executive of Association of the British Pharmaceutical Industry, told the Today programme he believes GlaxoSmithKline have since led "new ethical practices" and their culture has "dramatically changed".

He defends the industry as having "the highest standards" of clinical trial disclosure and marketing practices, as well as ensuring "absolute total transparency".

"We are truly trying to rebuild our social contract... and trying to address these trust issues," he told John Humphrys.


Get in touch with Today via email , Twitter or Facebook or text us on 84844.

SEE ALSO

Story Tools

BBC navigation

BBC © 2014 The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.

Americas Africa Europe Middle East South Asia Asia Pacific